Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Nov;56(9):5442-5452.
doi: 10.1111/ejn.15569. Epub 2022 Jan 17.

Role of proline-rich tyrosine kinase 2 (Pyk2) in the pathogenesis of Alzheimer's disease

Rahul Kumar  1 , Vishvanath Tiwari  2 , Sharmistha Dey  3
Affiliations
Review

Role of proline-rich tyrosine kinase 2 (Pyk2) in the pathogenesis of Alzheimer's disease

Rahul Kumar et al. Eur J Neurosci. 2022 Nov.

Abstract

Alzheimer's disease (AD), a progressive neurodegenerative disorder, is the most common form of dementia in the elderly. Two major pathological hallmarks have been identified for AD: extracellular amyloid plaques and intracellular neurofibrillary tangles (NFT). Recently, proline-rich tyrosine kinase 2 (Pyk2), which belongs to the focal adhesion kinase (FAK) non-receptor tyrosine kinase family, was recognized to contribute significantly towards the pathogenesis of AD. Pyk2 can influence the formation of amyloid plaques as well as NFTs. The kinase can directly phosphorylate tau, which is a significant component of NFTs and enhances tau pathology. Several competitive inhibitors have been developed for Pyk2, tested in several cancer models, as Pyk2 is known to be overexpressed under those conditions. The current review article discusses the possible mechanistic pathways by which Pyk2 can influence the pathogenesis of AD. Besides, it describes various inhibitors for Pyk2 and their potential role as therapeutics for AD in the future.

Keywords: amyloid; neurodegeneration; neurofibrillary tangles; tau kinase; tau phosphorylation.

PubMed Disclaimer

References

REFERENCES

    1. Ahmed, Z., Cooper, J., Murray, T. K., Garn, K., McNaughton, E., Clarke, H., Parhizkar, S., Ward, M. A., Cavallini, A., Jackson, S., Bose, S., Clavaguera, F., Tolnay, M., Lavenir, I., Goedert, M., Hutton, M. L., & O'Neill, M. J. (2014). A novel in vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: the pattern of spread is determined by connectivity, not proximity. Acta Neuropathologica, 127, 667-683. https://doi.org/10.1007/s00401-014-1254-6
    1. Alonso, A., Zaidi, T., Novak, M., Grundke-Iqbal, I., & Iqbal, K. (2001). Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments. Proceedings of the National Academy of Sciences of the United States of America, 98, 6923-6928. https://doi.org/10.1073/pnas.121119298
    1. Alonso, A. C., Li, B., Grundke-Iqbal, I., & Iqbal, K. (2006). Polymerization of hyperphosphorylated tau into filaments eliminates its inhibitory activity. Proceedings of the National Academy of Sciences of the United States of America, 103, 8864-8869.
    1. Alzheimer, A., Stelzmann, R. A., Schnitzlein, H. N., & Murtagh, F. R. (1995). An English translation of Alzheimer's 1907 paper, “Uber eine eigenartige Erkankung der Hirnrinde”. Clinical Anatomy, 8, 429-431. https://doi.org/10.1002/ca.980080612
    1. Alzheimer's Association. (2020). 2020 Alzheimer's disease facts and figures. Alzheimer's & Dementia, 16, 391-460. https://doi.org/10.1002/alz.12068

LinkOut - more resources